STRS Ohio’s Mustang Bio MBIO Stock Holding History

STRS Ohio’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5	Closed	-$20K	–	2113
2018 Q3	$20K	Sell	5 -2	-29%	-$10K	﹤0.01%	2038
2018 Q2	$33K	Buy	+7	New	+$44.2K	﹤0.01%	2025

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

FAM

Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return

STRS Ohio's MBIO Position: Q4 2018 in Review

STRS Ohio sold out of Mustang Bio (MBIO) in Q4 2018, closing a stake of 5 shares — an estimated $20K sold.

STRS Ohio first reported a position in MBIO in Q2 2018 and held it in 2 quarters. The position peaked at $33K in Q2 2018. 35 funds tracked by Wall St. Rank hold MBIO as of Q4 2018.

STRS Ohio reported no remaining Mustang Bio position as of Q4 2018 after selling out during the quarter.
STRS Ohio sold 5 Mustang Bio shares in Q4 2018, an estimated $20K.
STRS Ohio first reported a position in Mustang Bio in Q2 2018 and held it in 2 quarters.
STRS Ohio's Mustang Bio position peaked at $33K in Q2 2018.
35 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2018.

Based on STRS Ohio's 13F filing for Q4 2018, filed 23 Jan 2019.